These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 221885)

  • 21. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
    Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Active immunization of children exposed to varicella infection in hospitals, using subcutaneous and intradermal attenuated live vaccine].
    Boda D; Bartyik K; Szüts P; Turi S
    Orv Hetil; 1985 Oct; 126(42):2577-80. PubMed ID: 2997687
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of zoster immune globulin.
    Judelsohn RG; Meyers JD; Ellis RJ; Thomas EK
    Pediatrics; 1974 Apr; 53(4):476-80. PubMed ID: 4823323
    [No Abstract]   [Full Text] [Related]  

  • 31. [Does vaccination for chickenpox prevent herpes zoster? (interview by Waldtraut Paukstadt)].
    Doerr HW
    MMW Fortschr Med; 2002 Dec; 144(50):12. PubMed ID: 14610859
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive immunization against varicella in sick neonates by transfusion from donors immunologically enhanced by previous vaccination with live varicella vaccine.
    Isomura S; Nagai H; Kuroyanagi M; Horizawa S; Takahashi M
    Biken J; 1984 Sep; 27(2-3):133-6. PubMed ID: 6100051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella in children with cancer: impact of antiviral therapy and prophylaxis.
    Feldman S; Lott L
    Pediatrics; 1987 Oct; 80(4):465-72. PubMed ID: 2821476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Letter: Varicella prevention in persons with impaired immunoapparatus].
    Seip M; Lie SO
    Tidsskr Nor Laegeforen; 1974 Oct; 94(28):1934-5. PubMed ID: 4371630
    [No Abstract]   [Full Text] [Related]  

  • 36. Varicella prevention in the United States: a review of successes and challenges.
    Marin M; Meissner HC; Seward JF
    Pediatrics; 2008 Sep; 122(3):e744-51. PubMed ID: 18762511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience with varicella zoster immunoglobulin in Hungary].
    Nyerges G; Mészner Z; Héjjas M
    Orv Hetil; 1982 May; 123(22):1347-50. PubMed ID: 6287381
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe chickenpox during treatment with corticosteroids. At what age should varicella-zoster immunoglobulin be given?
    Buss P
    BMJ; 1995 Feb; 310(6975):327; author reply 328. PubMed ID: 7866184
    [No Abstract]   [Full Text] [Related]  

  • 40. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
    Wassilew SW
    MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.